The Role of the N-Terminal of the Prohormone Brain Natriuretic Peptide in Predicting Postoperative Multiple Organ Dysfunction Syndrome
Abstract
:1. Introduction
2. Methods
Statistical Analysis
3. Results
4. Discussion
5. Conclusions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Eugène, M.; Duchnowski, P.; Prendergast, B.; Wendler, O.; Laroche, C.; Monin, J.-L.; Jobic, Y.; Popescu, B.A.; Bax, J.J.; Vahanian, A.; et al. Contemporary Management of Severe Symptomatic Aortic Stenosis. J. Am. Coll. Cardiol. 2021, 78, 2131–2143. [Google Scholar] [CrossRef] [PubMed]
- Liu, Y.; Xiao, J.; Duan, X.; Lu, X.; Gong, X.; Chen, J.; Xiong, M.; Yin, S.; Guo, X.; Wu, Z. The multivariable prognostic models for severe complications after heart valve surgery. BMC Cardiovasc. Disord. 2021, 21, 491. [Google Scholar] [CrossRef] [PubMed]
- Duchnowski, P. N-Terminal of the Prohormone Brain Natriuretic Peptide Predicts Postoperative Cardiogenic Shock Requiring Extracorporeal Membrane Oxygenation. J. Clin. Med. 2022, 11, 5493. [Google Scholar] [CrossRef] [PubMed]
- Wu, M.-Y.; Yiang, G.-T.; Liao, W.-T.; Tsai, A.P.Y.; Cheng, Y.-L.; Cheng, P.-W.; Li, C.-Y.; Li, C.J. Current Mechanistic Concepts in Ischemia and Reperfusion Injury. Cell Physiol. Biochem. 2018, 46, 1650–1667. [Google Scholar] [CrossRef]
- Vashistha, T.; Streja, E.; Molnar, M.Z.; Rhee, C.M.; Moradi, H.; Soohoo, M.; Kovesdy, C.P.; Kalantar-Zadeh, K. Red cell distribution width and mortality in hemodialysis patients. Am. J. Kidney Dis. 2016, 68, 110–121. [Google Scholar] [CrossRef] [Green Version]
- Ronco, C. Hemodiafiltration: Technical and clinical issues. Blood Purif. 2015, 40, 2–11. [Google Scholar] [CrossRef]
- Siddiqui, M.; Paras, I.; Jalal, A. Risk factors of prolonged mechanical ventilation following open heart surgery: What has changed over the last decade? Cardiovasc. Diagn. Ther. 2012, 2, 192–199. [Google Scholar]
- Liu, Y.; An, Z.; Chen, J.; Liu, Y.; Tang, Y.; Han, Q.; Lu, F.; Tang, H.; Xu, Z. Risk factors for noninvasive ventilation failure in patients with post-extubation acute respiratory failure after cardiac surgery. J. Thorac. Dis. 2018, 10, 3319–3328. [Google Scholar] [CrossRef]
- Sheng, W.; Xing, Q.-S.; Hou, W.-M.; Sun, L.; Niu, Z.-Z.; Lin, M.-S.; Chi, Y.-F. Independent risk factors for ventilator-associated pneumonia after cardiac surgery. J. Investig. Surg. 2014, 27, 256–261. [Google Scholar] [CrossRef]
- Goyal, S.; Dashey, S.; Zlocha, V.; HannaJumma, S. The successful use of extra-corporeal membrane oxygenation as rescue therapy for unilateral pulmonary edema following minimally invasive mitral valve surgery. Perfusion 2019, 35, 356–359. [Google Scholar] [CrossRef]
- Duchnowski, P.; Hryniewiecki, T.; Kuśmierczyk, M.; Szymański, P. Red cell distribution width as a predictor of multiple organ dysfunction syndrome in patients undergoing heart valve surgery. Biol. Open 2018, 7, bio036251. [Google Scholar] [CrossRef] [PubMed]
- Yuan, X.; Lee, J.W.; Bowser, J.L.; Neudecker, V.; Sridhar, S.; Eltzschig, H.K. Targeting hypoxia signaling for perioperative organ injury. Anesth. Analg. 2018, 126, 308–321. [Google Scholar] [CrossRef] [PubMed]
- Fernandez-Zamora, M.D.; Gordillo-Brenes, A.; Banderas-Bravo, E.; Arboleda-Sánchez, J.A.; Hinojosa-Pérez, R.; Aguilar-Alonso, E.; Herruzo-Aviles, Á.; Curiel-Balsera, E.; Sánchez-Rodríguez, Á.; Rivera-Fernández, R. Prolonged mechanical ventilation as a predictor of mortality after cardiac surgery. Respir. Care 2018, 63, 550–557. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Yeung, K.K.; Groeneveld, M.; Lu, J.J.-N.; van Diemen, P.; Jongkind, V.; Wisselink, W. Organ protection during aortic cross-clamping. Best Pract. Res. Clin. Anaesthesiol. 2016, 30, 305–315. [Google Scholar] [CrossRef]
- Roberts, E.; Ludman, A.J.; Dworzynski, K.; Al-Mohammad, A.; Cowie, M.R.; McMurray, J.J.; Mant, J. The diagnostic accuracy of the natriuretic peptides in heart failure: Systematic review and diagnostic meta-analysis in the acute care setting. BMJ 2015, 350, 910. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Weber, M.; Arnold, R.; Rau, M.; Brandt, R.; Berkovitsch, A.; Mitrovic, V.; Hamm, C. Relation of N-terminal pro-B-type natriuretic peptide to severity of valvular aortic stenosis. Am. J. Cardiol. 2004, 94, 740–745. [Google Scholar] [CrossRef] [PubMed]
- Sezai, A.; Shiono, M. Natriuretic peptides for perioperative management of cardiac surgery. J. Cardiol. 2016, 67, 15–21. [Google Scholar] [CrossRef] [Green Version]
- Maisel, A.; Mueller, C.; Adams, K., Jr.; Anker, S.D.; Aspromonte, N.; Cleland, J.G.; Cohen-Solal, A.; Dahlstrom, U.; DeMaria, A.; Di Somma, S.; et al. State of the art: Using natriuretic peptide levels in clinical practice. Eur. J. Heart Fail. 2008, 10, 824–839. [Google Scholar] [CrossRef]
- Bion, J.F. Susceptibility to critical illness: Reserve, response and therapy. Intens. Care Med. 2000, 26, S057–S063. [Google Scholar] [CrossRef]
- Desai, A.S.; Jarcho, J.A. Levosimendan for the Low Cardiac Output Syndrome after Cardiac Surgery. N. Engl. J. Med. 2017, 376, 2076–2078. [Google Scholar] [CrossRef]
- Ponikowski, P.; Voors, A.A.; Anker, S.D.; Bueno, H.; Cleland, J.G.F.; Coats, A.J.S.; Falk, V.; González-Juanatey, J.R.; Harjola, V.P.; Jankowska, E.A.; et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur. Heart J. 2016, 37, 2129–2200. [Google Scholar] [PubMed]
- Krichevskiy, L.A.; Kozlov, I.A. Natriuretic Peptides in Cardiac Anesthesia and Intensive Care. J. Cardiothorac. Vasc. Anesth. 2019, 33, 1407–1419. [Google Scholar] [CrossRef] [PubMed]
- McDonagh, T.A.; Metra, M.; Adamo, M.; Gardner, R.S.; Baumbach, A.; Böhm, M.; Burri, H.; Butler, J.; Čelutkienė, J.; Chioncel, O.; et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur. Heart J. 2021, 42, 3599–3726. [Google Scholar] [CrossRef] [PubMed]
- Weidemann, F.; Herrmann, S.; Störk, S.; Niemann, M.; Frantz, S.; Lange, V.; Beer, M.; Gattenlöhner, S.; Voelker, W.; Ertl, G.; et al. Impact of myocardial fibrosis in patients with symptomatic severe aortic stenosis. Circulation 2009, 120, 577–584. [Google Scholar] [CrossRef] [Green Version]
- Chin, C.W.; Shah, A.S.; McAllister, D.A.; Joanna Cowell, S.; Alam, S.; Langrish, J.P.; Strachan, F.E.; Hunter, A.L.; Maria Choy, A.; Lang, C.C.; et al. High-sensitivity troponin I concentrations are a marker of an advanced hypertrophic response and adverse outcomes in patients with aortic stenosis. Eur. Heart J. 2014, 35, 2312–2321. [Google Scholar] [CrossRef] [PubMed]
- Miceli, A.; Romeo, F.; Glauber, M.; de Siena, P.M.; Caputo, M.; Angelini, G.D. Preoperative anemia increases mortality and postoperative morbidity after cardiac surgery. J. Cardiothorac. Surg. 2014, 9, 137. [Google Scholar] [CrossRef] [Green Version]
- Joshi, S.S.; George, A.; Manasa, D.; Savita, H.M.; Krishna, P.T.; Jagadeesh, A.M. Propensity-matched analysis of association between preoperative anemia and in-hospital mortality in cardiac surgical patients undergoing valvular heart surgeries. Ann. Card Anaesth. 2015, 18, 373–379. [Google Scholar]
- Elmistekawy, E.; Rubens, F.; Hudson, C.; McDonald, B.; Ruel, M.; Lam, K.; Mesana, T.G.; Boodhwani, M. Preoperative anaemia is a risk factor for mortality and morbidity following aortic valve surgery. Eur. J. Cardiothorac. Surg. 2013, 44, 1051–1055. [Google Scholar] [CrossRef]
Patient Characteristics (n = 602) | Values |
---|---|
Age, years * | 64 ± 11 |
Atrial fibrillation, n (%) | 263 (43%) |
Body mass index, kg/m2 * | 27 ± 7 |
Diabetes mellitus, n (%) | 112 (18%) |
EuroSCORE II, (%) * | 3.3 ± 3.0 |
Male: men, n (%) | 347 (58%) |
NYHA, (classes) * | 2.6 ± 0.5 |
GFR, mL/min/1.73 m2 * | 67 ± 17 |
Hemoglobin, g/dL * | 13.7 ± 1.5 |
Hs-TnT, ng/L * | 35 ± 27 |
NT-proBNP, pg/mL * | 2012 ± 1504 |
LV ejection fraction, (%) * | 58 ± 11 |
TAPSE, mm * | 21 ± 8 |
RVSP, mmHg * | 45 ± 18 |
Medications | |
Antihypertensive drugs (beta blockers, ACEi, ARBs, calcium blockers, diuretics) (%), n (%) | 450 (74%) |
Oral antidiabetic drugs, n (%) | 110 (18%) |
Insulin, n (%) | 22 (3%) |
Statins, n (%) | 222 (37%) |
Anticoagulants, n (%) | 263 (43%) |
Intra- and postoperative characteristics of patients | |
Aortic valve replacement, n (%) | 302 (50%) |
Aortic valve plasty, n (%) | 11 (2%) |
Mitral valve replacement, n (%) | 108 (18%) |
Aortic valve replacement + mitral valve replacement, n (%) | 52 (9%) |
Mitral valve plasty, n (%) | 113 (18%) |
Tricuspid valve plasty and replacement, n (%) | 16 (3%) |
Additional procedure Coronary artery bypass graft, n (%) | 87 (14%) |
Aortic cross-clamp time, min * | 102 ± 31 |
Cardiopulmonary bypass time, min * | 135 ± 56 |
Univariable | Multivariable | |||||
---|---|---|---|---|---|---|
Variable | Odds Ratio | 95% Cl | p-Value | Odds Ratio | 95% Cl | p-Value |
Hemoglobin, g/dL | 0.525 | 0.422–0.654 | <0.001 | 0.653 | 0.503–0.847 | 0.003 |
NT-proBNP, pg/mL | 1.022 | 1.011–1.033 | <0.001 | 1.026 | 1.012–1.041 | 0.001 |
Age, years | 1.069 | 1.030–1.109 | 0.004 | |||
GFR, mL/min/1.73 m2 | 0.965 | 0.947–0.984 | 0.002 | |||
LV ejection fraction, (%) | 0.969 | 0.946–0.992 | 0.009 | |||
RVSP, mmHg | 1.022 | 1.005–1.039 | 0.01 | |||
Cardiopulmonary bypass time, min * | 1.040 | 0.972–1.121 | 0.08 |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Duchnowski, P. The Role of the N-Terminal of the Prohormone Brain Natriuretic Peptide in Predicting Postoperative Multiple Organ Dysfunction Syndrome. J. Clin. Med. 2022, 11, 7217. https://doi.org/10.3390/jcm11237217
Duchnowski P. The Role of the N-Terminal of the Prohormone Brain Natriuretic Peptide in Predicting Postoperative Multiple Organ Dysfunction Syndrome. Journal of Clinical Medicine. 2022; 11(23):7217. https://doi.org/10.3390/jcm11237217
Chicago/Turabian StyleDuchnowski, Piotr. 2022. "The Role of the N-Terminal of the Prohormone Brain Natriuretic Peptide in Predicting Postoperative Multiple Organ Dysfunction Syndrome" Journal of Clinical Medicine 11, no. 23: 7217. https://doi.org/10.3390/jcm11237217
APA StyleDuchnowski, P. (2022). The Role of the N-Terminal of the Prohormone Brain Natriuretic Peptide in Predicting Postoperative Multiple Organ Dysfunction Syndrome. Journal of Clinical Medicine, 11(23), 7217. https://doi.org/10.3390/jcm11237217